» Articles » PMID: 22542757

The Effect of a Novel Tobacco Process on the in Vitro Cytotoxicity and Genotoxicity of Cigarette Smoke Particulate Matter

Overview
Specialty Toxicology
Date 2012 May 1
PMID 22542757
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Some of the toxic effects of smoking have been attributed to the combustion of nitrogenous protein in tobacco. The effects of a treatment which reduces tobacco's protein nitrogen level, on the in vitro cytotoxicity and genotoxicity of cigarette smoke particulate matter (PM), were measured. PMs were tested in the Neutral Red Uptake (NRU) test; the Salmonella mutagenicity assay (SAL); the mouse lymphoma mammalian cell mutation assay (MLA) and the in vitro micronucleus test (IVMNT). PMs from all of the cigarettes were cytotoxic and genotoxic. PM obtained from smoking treated tobacco, showed a small, consistent and statistically significant reduced mutagenicity (revertants/μg) in TA98 with post-mitochondrial supernatant (S9). No consistent quantitative or qualitative differences were detected in the other tests. The data are discussed in relation to published information on smoke chemistry obtained from cigarettes made of tobacco treated using this technique. The observations confirm that the method did not give rise to any new qualitative or quantitative cytotoxic or genotoxic effects, and may have reduced PM's bacterial mutagenicity in TA98 with S9. Further toxicity testing is warranted, to investigate the effects of the tobacco treatment in more detail and add to the data already obtained.

Citing Articles

Differences in Airway Remodeling and Emphysematous Lesions between Rats Exposed to Smoke from New-Type and Conventional Tobacco Varieties.

Wei K, Li Y, Du B, Wu J Antioxidants (Basel). 2024; 13(5).

PMID: 38790616 PMC: 11117731. DOI: 10.3390/antiox13050511.


New Approach Methods to Evaluate Health Risks of Air Pollutants: Critical Design Considerations for In Vitro Exposure Testing.

Zavala J, Freedman A, Szilagyi J, Jaspers I, Wambaugh J, Higuchi M Int J Environ Res Public Health. 2020; 17(6).

PMID: 32210027 PMC: 7143849. DOI: 10.3390/ijerph17062124.


mutagenicity of gas-vapour phase extracts from flavoured and unflavoured heated tobacco products.

Godec T, Crooks I, Scott K, Meredith C Toxicol Rep. 2019; 6:1155-1163.

PMID: 31737489 PMC: 6849343. DOI: 10.1016/j.toxrep.2019.10.007.


Approaches for the design of reduced toxicant emission cigarettes.

Dittrich D, Fieblekorn R, Bevan M, Rushforth D, Murphy J, Ashley M Springerplus. 2014; 3:374.

PMID: 25110628 PMC: 4125608. DOI: 10.1186/2193-1801-3-374.


Characterisation of an aerosol exposure system to evaluate the genotoxicity of whole mainstream cigarette smoke using the in vitro γH2AX assay by high content screening.

Garcia-Canton C, Errington G, Anadon A, Meredith C BMC Pharmacol Toxicol. 2014; 15:41.

PMID: 25056295 PMC: 4122049. DOI: 10.1186/2050-6511-15-41.